POS1454-HPR AESTHETIC IMPAIRMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS: A CASE CONTROL STUDY USING A SEMI-QUANTITATIVE SCALE FOR BODY IMAGE ASSESSMENT

Background: Systemic sclerosis (SSc) is a fibrotic autoimmune disease characterized by dermatological involvement. Skin involvement can alter appearance, which have psychological impact(1). Assessment of body image could be central in optimizing care. Yet, data are scarce(2). Objectives: The main objective our study was to assess aesthetic impairment measured on visual scale (AES) (3) patients with SSc compared group healthy subjects. Secondary objectives were associations between and standardized questionnaires for as well clinical, biological, psychological/quality life, functional parameters SSc. Methods: “Sclero-esthet” descriptive single-center two populations: SSc, included referral center systemic diseases at Lille Hospital, France, controls. Results: This study, from January 2017 October 2017, 88 (69 [78.4%] women) median age 52 years (range: 43 59) controls (49 [55.7%] 45 32 55). Perception physical changes assessed using the AES greater cases than (3.7 ± 0.3 vs 2.8 0.3, p=0.028), statistical correlation ASWAP. anxiety or depressive symptoms had significantly higher scores. Cases presented poorer quality life Conclusion: appears good tool evaluate impairment. Correlations found support need improve patient management this field. References: [1]Cash TF. Body image: past, present, future. Image 2004;1(1):1–5. [2]Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM. dissatisfaction among women scleroderma: extent relationship psychosocial function. Health Psychol mars. 2003;22(2):130–9. [3]Nguyen Ranque Baubet T, Bérezné A, Mestre-Stanislas Rannou F, et al. Clinical, Functional Health-Related Quality Life Correlates Clinically Significant Symptoms Anxiety Depression Patients Sclerosis: A Cross-Sectional Survey. PLoS ONE 2014;9(2). [4]Heinberg Kudel I, Kwan Medley K, F. Assessing (scleroderma): Validation Adapted Satisfaction Appearance Scale. 2007;4(1):79–86. Disclosure Interests: None declared